Quick Answer
Harvard Apparatus Regenerative Technology, Inc. reported Operating Income Loss of -$6.92 million for the year ending 2025.
- Harvard Apparatus Regenerative Technology, Inc. showed an increase of +10.5% in Operating Income Loss from 2024 to 2025.
- This data is from Harvard Apparatus Regenerative Technology, Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), Harvard Apparatus Regenerative Technology, Inc.'s Operating Income Loss has declined by 3.0%.
- Historical annual values: Fiscal year 2025: -$6.92 million | Fiscal year 2024: -$7.73 million | Fiscal year 2023: -$8.99 million | Fiscal year 2022: -$6.15 million | Fiscal year 2021: -$8.64 million | Fiscal year 2020: -$5.33 million | Fiscal year 2019: -$8.87 million | Fiscal year 2018: -$7.84 million | Fiscal year 2017: -$11.47 million | Fiscal year 2016: -$12.13 million | Fiscal year 2015: -$11.70 million | Fiscal year 2014: -$11.06 million | Fiscal year 2013: -$8.82 million | Fiscal year 2012: -$6.71 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: